R1 RCM Inc (NASDAQ:RCM) Expected to Post FY2019 Earnings of $0.00 Per Share

R1 RCM Inc (NASDAQ:RCM) – Equities research analysts at Cantor Fitzgerald reduced their FY2019 earnings per share (EPS) estimates for shares of R1 RCM in a report issued on Wednesday, November 6th. Cantor Fitzgerald analyst S. Halper now anticipates that the healthcare provider will post earnings of $0.00 per share for the year, down from their previous estimate of $0.03.

A number of other research analysts also recently weighed in on RCM. BidaskClub upgraded R1 RCM from a “sell” rating to a “hold” rating in a research note on Wednesday. Zacks Investment Research upgraded R1 RCM from a “hold” rating to a “buy” rating and set a $10.00 price target for the company in a research note on Wednesday, October 9th. ValuEngine upgraded R1 RCM from a “sell” rating to a “hold” rating in a research note on Friday, November 1st. Finally, Robert W. Baird set a $14.00 price target on R1 RCM and gave the company a “buy” rating in a research note on Thursday, September 12th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $13.40.

NASDAQ:RCM opened at $11.84 on Friday. The company has a debt-to-equity ratio of 29.28, a quick ratio of 0.90 and a current ratio of 0.94. The company has a market cap of $1.29 billion, a PE ratio of -37.00 and a beta of 0.15. R1 RCM has a 52-week low of $7.10 and a 52-week high of $13.19. The stock has a 50-day simple moving average of $10.01 and a 200 day simple moving average of $11.40.

R1 RCM (NASDAQ:RCM) last posted its quarterly earnings data on Tuesday, November 5th. The healthcare provider reported $0.01 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.09 by ($0.08). The firm had revenue of $301.20 million for the quarter, compared to the consensus estimate of $302.85 million. R1 RCM had a positive return on equity of 100.31% and a negative net margin of 0.13%. The firm’s quarterly revenue was up 20.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.17) earnings per share.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Hedge funds have recently bought and sold shares of the business. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in R1 RCM by 38.8% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,817 shares of the healthcare provider’s stock valued at $52,000 after purchasing an additional 1,625 shares in the last quarter. Aperio Group LLC acquired a new stake in shares of R1 RCM in the second quarter valued at approximately $127,000. NumerixS Investment Technologies Inc lifted its position in shares of R1 RCM by 73.3% in the second quarter. NumerixS Investment Technologies Inc now owns 10,400 shares of the healthcare provider’s stock valued at $131,000 after buying an additional 4,400 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. acquired a new stake in shares of R1 RCM in the second quarter valued at approximately $139,000. Finally, Bank of Montreal Can lifted its position in shares of R1 RCM by 179.5% in the second quarter. Bank of Montreal Can now owns 13,308 shares of the healthcare provider’s stock valued at $168,000 after buying an additional 8,547 shares during the last quarter. Hedge funds and other institutional investors own 71.10% of the company’s stock.

R1 RCM Company Profile

R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.

Further Reading: Is it better to buy a fund with a higher or lower NAV?

Earnings History and Estimates for R1 RCM (NASDAQ:RCM)

Leave a Reply

Your email address will not be published. Required fields are marked *

*